Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Monitoring Filling Room Air Quality – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Monitoring Filling Room Air Quality – V 2.0

Standard Operating Procedure for Monitoring Filling Room Air Quality


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/128/2025
Supersedes SOP/SIM/128/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To establish a validated procedure for monitoring the air quality in sterile injectable filling rooms to ensure aseptic processing conditions are maintained and product sterility is not compromised.

2. Scope

This SOP applies to all sterile injectable filling rooms

in classified areas (Grade A/B/C) within the manufacturing facility. It includes routine environmental monitoring (EM) using viable and non-viable methods.

3. Responsibilities

  • Microbiology Personnel: Perform routine air sampling, documentation, and trend analysis.
  • Production Operators: Ensure cooperation during monitoring and report abnormalities.
  • Quality Assurance (QA): Review and approve EM records.
  • Engineering: Maintain AHU systems and particle counters.
See also  Sterile Injectable Manufacturing: SOP for Subcutaneous Injection Batch Manufacturing - V 2.0

4. Accountability

The QA Head is accountable for ensuring compliance to this SOP and reviewing EM data for action and compliance decisions.

5. Procedure

5.1 Classification of Areas

  1. Identify and categorize filling rooms into:
    • Grade A: Laminar Air Flow (LAF) zones where open vial/syringe filling occurs
    • Grade B: Background to Grade A
    • Grade C: Preparation and gowning areas

5.2 Monitoring Parameters

  1. Parameters to monitor:
    • Viable Particles (microbial contamination)
    • Non-Viable Particles (0.5 μm and 5.0 μm)
    • Temperature and Relative Humidity (RH)
    • Differential Pressure

5.3 Monitoring Frequency

  1. Grade A: Continuous for non-viable particles; viable particles every shift.
  2. Grade B: Once per shift (viable), twice daily (non-viable).
  3. Grade C: Daily (viable), once daily (non-viable).
  4. Temperature, RH, and differential pressure: Monitored continuously or at least twice per shift.

5.4 Sampling Locations and Methods

  1. Define locations as per Risk Assessment and Validation Report.
  2. Use the following methods:
    • Air Sampler (active sampling) – 1000 L volume
    • Settle Plates – Expose for 4 hours
    • Contact Plates – For surface checks
    • Particle Counters – Installed/portable units
See also  Formulation Development: SOP for Documentation in Product Development - V 2.0

5.5 Alert and Action Limits

  1. Refer to Annexure-1 for limits by grade and parameter.
  2. Investigate any values that exceed alert/action levels using the EM Deviation Investigation Form (Annexure-2).

5.6 Data Review and Trending

  1. Microbiology to review and record results daily.
  2. Compile monthly trend reports (Annexure-3).
  3. QA to review and initiate corrective actions if required.

5.7 Equipment Calibration and Maintenance

  1. Ensure all EM instruments are calibrated per schedule.
  2. Document calibration certificates and paste copies with Annexure-4.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • EM: Environmental Monitoring
  • LAF: Laminar Air Flow
  • QA: Quality Assurance
  • AHU: Air Handling Unit

7. Documents

  1. Environmental Monitoring Limits Table – Annexure-1
  2. EM Deviation Investigation Form – Annexure-2
  3. Monthly Trend Report Format – Annexure-3
  4. Calibration Certificate Log – Annexure-4

8. References

  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • WHO Technical Report Series 961
  • ISO 14644-1 and 14698 standards
See also  Sterile Injectable Manufacturing: SOP for Use of Weighing Balances for Material Dispensing - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Environmental Monitoring Limits Table

Grade Viable (cfu/m³) Non-Viable 0.5μm (particles/m³) Temperature (°C) RH (%)
A <1 3520 20–22 ≤55
B 10 35200 20–22 ≤55
C 100 352000 20–23 ≤60

Annexure-2: EM Deviation Investigation Form

Date Location Parameter Observed Value Investigation Outcome Corrective Action
21/06/2025 LAF-1 Viable 3 cfu/m³ Operator-related breach Retraining conducted

Annexure-3: Monthly Trend Report Format

Month Location Average Viable Average Non-Viable Alert/Action Events
June 2025 Filling Room 0.4 2900 2

Annexure-4: Calibration Certificate Log

Instrument ID No. Calibration Date Next Due Performed By
Particle Counter PC-005 01/06/2025 01/12/2025 Sunil Mehta

Revision History

Revision Date Revision No. Details Reason Approved By
15/03/2022 1.0 Initial SOP Release New Process QA Head
24/06/2025 2.0 Updated sampling methods, added calibration log Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Role of the Quality Unit in SOP Development in Pharma
Next Post: Absence of SOP for Self-Inspections and Internal Audits: A Critical GMP Gap

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version